Zeon Lifesciences expands its footprints in the global market to reach out larger audience and provide greater product varieties

New Delhi, 2nd May 2023: Zeon Lifesciences India’s largest Contract Research and Manufacturing Services (CRAMS) Organization, today announced that it is further expanding its footprints to 13+ countries in the FY 2023 - 24, after having made its significant presence across various regions including SEA, MENA, GEC, with its wide array of Nutrition Wellness & Ayurvedic products.

Committed to its mission of nurturing life with well-researched health and wellness products, the company is set to expand with its line of products, compliant with the highest safety & efficacy standards and 15+ accreditations such as US FDA registered, NSF USA, SEDEX, WHO GMP, Ministry of Ayush, FSSAI, NABL Quality Lab, DSIR certified R&D, etc.

With an extensive focus on innovation, Zeon has collaborated with the country's many top research organizations, academic associations, and agencies for technology transfer, patent filing, and clinical validation. The company possesses over 250+ formulations and 625+ product SKUs in various categories, including General, Functional, Disease-specific, Nutraceuticals, Performance, Phyto-nutrition, Veterinary, and Ayurvedic Proprietary Medicine Products, etc. The brand has also commercialized various premium nutraceutical and herbal product categories in human and pet animal nutrition including ‘formulated sublingual sprays’, ‘Enzyme syrup for gut health’, ‘pet nutrition products, etc.

Commenting on the growth and the future plans Yashna Garg, CMO at Zeon Lifesciences says “Since India is becoming a hub for nutraceutical products, it is a broader chance for us to consider this opportunity and provide the best of the product in the country. Hence, we are excited to introduce new categories that we have been developing and testing. We hope that these categories will benefit the masses”.

“We are committed to staying at the forefront of innovation and new technology in this space and believe that our ongoing investments in research and development will enable us to continue to bring new and exciting products to market. We look forward to sharing more updates on our product diversification plans in the near future” She added.

Zeon has a State- of- the art manufacturing facility at Paonta Sahib, Himachal Pradesh,  spread across 28000sq. Yards. Also, Zeon life science has products registered under COPP and many more in the pipeline for launching in various countries. COPP, (Certificate of Pharmaceutical Product), is a document issued by a national regulatory authority to certify that the product has been authorized for sale in a particular country or region. It serves as proof that the product has met the regulatory requirements of that country or region and is safe, effective, and of good quality. COPP is commonly required for products to be imported, exported, or registered in various countries.  Zeon Lifescience also has products registered under WHO-GMP for Ayurvedic products and signifies their commitment to quality and regulatory compliance as per the guidance of the Ministry of Ayush. Zeon is the only company in the country that consolidates 4 manufacturing units under an integrated complex, including the Spray dried powder, dry blended powder, tablets, capsules, diskettes, Premixes, tablets, capsules, diskettes, and liquid oral liquid sprays and liquid orals.